aclacinomycin has been researched along with Lung Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Umezawa, H | 1 |
| Homma, T; Min, KY; Nakagawa, H; Yoneda, S; Yoshida, S | 1 |
| Fujii, M; Fujita, Y; Ishimitsu, T; Okabe, K; Toki, H | 1 |
| Coley, HM; Twentyman, PR; Workman, P | 2 |
| Chen, R; Chen, Y; Hu, Q; Jiao, H; Shen, W; Wang, H; Wang, Y; Zhou, M | 1 |
| Izumi, H; Shirai, M; Yamagami, T | 1 |
| Feng, JB; Han, R; Li, ZR; Xia, LJ; Yin, MB | 1 |
8 other study(ies) available for aclacinomycin and Lung Neoplasms
| Article | Year |
|---|---|
Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
Topics: Aclarubicin; Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Bleomycin; Daunorubicin; Doxorubicin; Humans; Leukemia L1210; Lung; Lung Neoplasms; Mice; Molecular Weight; Naphthacenes; Peplomycin; Structure-Activity Relationship | 1982 |
[Aclacinomycin; benefits for the treatment of malignant pleural effusion].
Topics: Aclarubicin; Adenocarcinoma; Aged; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Naphthacenes; Pleural Effusion; Rabbits | 1983 |
[Efficacy of intrapleural treatment with aclacinomycin combined with closed tube thoracostomy for malignant pleural effusion].
Topics: Aclarubicin; Adenocarcinoma; Adult; Aged; Drainage; Female; Humans; Intubation; Lung Neoplasms; Male; Middle Aged; Naphthacenes; Pleural Effusion; Thorax | 1984 |
Further examination of 9-alkyl- and sugar-modified anthracyclines in the circumvention of multidrug resistance.
Topics: Aclarubicin; Animals; Carcinoma, Small Cell; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Structure-Activity Relationship; Tumor Cells, Cultured | 1992 |
Antitumor activity of siwenmycin: a novel anthracycline antibiotic.
Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; DNA, Neoplasm; Doxorubicin; HeLa Cells; Humans; Injections, Intraperitoneal; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred Strains; Mitolactol; Mitomycins; Neoplasm Metastasis; RNA, Neoplasm; Tumor Cells, Cultured | 1992 |
Experimental transplantation models of mouse sarcoma 180 in ICR mice for evaluation of anti-tumor drugs.
Topics: Aclarubicin; Animals; Antineoplastic Agents; Daunorubicin; Disease Models, Animal; Doxorubicin; Lung Neoplasms; Male; Mice; Mice, Inbred ICR; Neoplasm Transplantation; Sarcoma 180; Skin Neoplasms; Specific Pathogen-Free Organisms | 1991 |
9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance.
Topics: Aclarubicin; Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Doxorubicin; Drug Resistance; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Mice; Neoplasm Proteins; Tumor Cells, Cultured | 1990 |
[Effect of aclacinomycin B on DNA polymerase II of tumor cells].
Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; DNA Polymerase II; Leukemia L1210; Lung Neoplasms; Mice; Naphthacenes; Neoplasms, Experimental | 1985 |